Login

Survival Without Quality of Life Deterioration in the GORTEC 2014-04 “OMET” Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR

Ablative case
DOI: 10.1016/j.ijrobp.2024.11.084 Publication Date: 2024-11-28T17:18:12Z
Abstract Supplemental Material References Cited by
AUTHORS (34)
Juliette Thariat
Mathieu Bosset
Antoine Falcoz
Dewi Vernerey
Yoann Pointreau
Severine Racadot
Jean-Christophe F...
Joel Castelli
Sebastien Guihard
Florence Huguet
Sophie Chapet
Yungan Tao
Christian Borel
Jerome Fayette
Audrey Rambeau
François-Régis Fe...
Adeline Pechery
Jean Bourhis
Xu-Shan Sun
Juliette Thariat
Mathieu Bosset
Yoann Pointreau
Severine Racadot
Jean-Christophe F...
Joel Castelli
Sebastien Guihard
Florence Huguet
Sophie Chapet
Yungan Tao
Christian Borel
Jerome Fayette
Adeline Pechery
Jean Bourhis
Xu-Shan Sun
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (3)
EXTERNAL LINKS
OPENAIRE - Products  CROSSREF - Publications  OPENALEX - Publications 
PlumX Metrics
Survival Without Quality of Life Deterioration in the GORTEC 2014-04 “OMET” Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR 
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....

Powered by

  • AIX SEMS NFDI4DS

Legal

  • Impressum Datenschutz

Connect